Product Surveillance, Postmarketing
"Product Surveillance, Postmarketing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale.
Concept/Terms
Product Surveillance, Postmarketing- Product Surveillance, Postmarketing
- Product Surveillance, Post-Marketing
- Post-Marketing Product Surveillance
- Post-Marketing Product Surveillances
- Product Surveillance, Post Marketing
- Product Surveillances, Post-Marketing
- Surveillance, Post-Marketing Product
- Surveillances, Post-Marketing Product
- Evaluation Studies, Postmarketing
- Evaluation Study, Postmarketing
- Postmarketing Evaluation Studies
- Postmarketing Evaluation Study
- Studies, Postmarketing Evaluation
- Study, Postmarketing Evaluation
- Postmarketing Product Surveillance
- Postmarketing Product Surveillances
- Product Surveillances, Postmarketing
- Surveillance, Postmarketing Product
- Surveillances, Postmarketing Product
Drug Surveillance, Postmarketing- Drug Surveillance, Postmarketing
- Drug Surveillances, Postmarketing
- Postmarketing Drug Surveillance
- Postmarketing Drug Surveillances
- Surveillance, Postmarketing Drug
- Surveillances, Postmarketing Drug
Below are MeSH descriptors whose meaning is more general than "Product Surveillance, Postmarketing".
Below are MeSH descriptors whose meaning is more specific than "Product Surveillance, Postmarketing".
This graph shows the total number of publications written about "Product Surveillance, Postmarketing" by people in Harvard Catalyst Profiles by year, and whether "Product Surveillance, Postmarketing" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 1 | 2 | 3 |
| 1993 | 1 | 1 | 2 |
| 1994 | 2 | 0 | 2 |
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 2 | 3 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 2 | 1 | 3 |
| 2003 | 0 | 4 | 4 |
| 2004 | 1 | 1 | 2 |
| 2005 | 4 | 5 | 9 |
| 2006 | 3 | 2 | 5 |
| 2007 | 4 | 5 | 9 |
| 2008 | 4 | 6 | 10 |
| 2009 | 7 | 4 | 11 |
| 2010 | 6 | 4 | 10 |
| 2011 | 8 | 7 | 15 |
| 2012 | 19 | 9 | 28 |
| 2013 | 17 | 14 | 31 |
| 2014 | 16 | 6 | 22 |
| 2015 | 13 | 8 | 21 |
| 2016 | 7 | 3 | 10 |
| 2017 | 9 | 7 | 16 |
| 2018 | 6 | 10 | 16 |
| 2019 | 13 | 7 | 20 |
| 2020 | 10 | 9 | 19 |
| 2021 | 5 | 1 | 6 |
Below are the most recent publications written about "Product Surveillance, Postmarketing" by people in Profiles.
-
How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? AMA J Ethics. 2021 09 01; 23(9):E673-678.
-
FDA Regulation and Approval of Medical Devices: 1976-2020. JAMA. 2021 08 03; 326(5):420-432.
-
A Broad Safety Assessment of the 9-Valent Human Papillomavirus Vaccine. Am J Epidemiol. 2021 07 01; 190(7):1253-1259.
-
Global covid-19 vaccine rollout and safety surveillance-how to keep pace. BMJ. 2021 06 18; 373:n1416.
-
Active Surveillance of the Safety of Medications Used During Pregnancy. Am J Epidemiol. 2021 06 01; 190(6):1159-1168.
-
A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System. Pharmacoepidemiol Drug Saf. 2021 07; 30(7):827-837.
-
Maternal and neonatal data collection systems in low- and middle-income countries for maternal vaccines active safety surveillance systems: A scoping review. BMC Pregnancy Childbirth. 2021 Mar 17; 21(1):217.
-
Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the De Novo Pathway Between 2011 and 2019. JAMA Intern Med. 2020 12 01; 180(12):1701-1703.
-
Assessment of quality of life changes in patients with lower extremity lymphedema using an advanced pneumatic compression device at home. J Vasc Surg Venous Lymphat Disord. 2021 05; 9(3):745-752.
-
Leveraging the Capabilities of the FDA's Sentinel System To Improve Kidney Care. J Am Soc Nephrol. 2020 11; 31(11):2506-2516.